Opyl Ltd Market Cap ($4.82 Million)
Market Cap & Net Worth: Opyl Ltd (OPL)
Opyl Ltd market cap. Opyl Ltd (AU:OPL) has a market capitalization of $4.82 Million (AU$6.81 Million) as of November 2, 2026. Listed on the AU stock exchange, this Australia-based company holds position #28608 globally and #1509 in its home market, demonstrating a 0.00% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Opyl Ltd's stock price AU$0.02 by its total outstanding shares 296081984 (296.08 Million). Also see OPL operating cash flow for how efficiently the company converts equity into cash flow.
Opyl Ltd Market Cap History (2015–2025)
Opyl Ltd market cap history from 2015 to 2025. Data shows change from $1.89 Billion to $4.82 Million (-45.14% CAGR). Check OPL stock price and chart for real-time trading data and today's change.
Opyl Ltd Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Opyl Ltd's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Explore net asset growth rate of Opyl Ltd to track how rapidly the company is growing its equity base year over year.
Latest Price to Sales (P/S) Ratio
10.01x
Opyl Ltd's market cap is 10.01 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2015 | $1.89 Billion | $63.46K | -$4.48 Million | 29709.31x | N/A |
| 2016 | $230.45 Million | $56.04K | -$6.08 Million | 4112.40x | N/A |
| 2017 | $104.75 Million | $219.45K | -$3.23 Million | 477.31x | N/A |
| 2018 | $41.90 Million | $413.56K | -$3.04 Million | 101.31x | N/A |
| 2019 | $29.33 Million | $927.04K | -$3.10 Million | 31.64x | N/A |
| 2020 | $36.66 Million | $620.78K | -$926.00K | 59.06x | N/A |
| 2021 | $24.09 Million | $767.72K | -$1.14 Million | 31.38x | N/A |
| 2022 | $6.08 Million | $902.41K | -$2.09 Million | 6.73x | N/A |
| 2023 | $5.87 Million | $617.91K | -$1.73 Million | 9.49x | N/A |
| 2024 | $3.98 Million | $397.64K | -$3.13 Million | 10.01x | N/A |
Competitor Companies of OPL by Market Capitalization
Companies near Opyl Ltd in the global market cap rankings as of November 2, 2026. Also see how large is Opyl Ltd's balance sheet for a full breakdown of the balance sheet.
Key companies related to Opyl Ltd by market ranking:
- Veeva Systems Inc Class A (NYSE:VEEV): Ranked #719 globally with a market cap of $37.44 Billion USD.
- Pro Medicus Ltd (AU:PME): Ranked #1627 globally with a market cap of $14.50 Billion USD ( AU$20.50 Billion AUD).
- Tempus AI, Inc. Class A Common Stock (NASDAQ:TEM): Ranked #2005 globally with a market cap of $11.06 Billion USD.
- BrightSpring Health Services, Inc. Common Stock (NASDAQ:BTSG): Ranked #2067 globally with a market cap of $10.63 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #719 | Veeva Systems Inc Class A | NYSE:VEEV | $37.44 Billion | $312.96 |
| #1627 | Pro Medicus Ltd | AU:PME | $14.50 Billion | AU$196.20 |
| #2005 | Tempus AI, Inc. Class A Common Stock | NASDAQ:TEM | $11.06 Billion | $72.22 |
| #2067 | BrightSpring Health Services, Inc. Common Stock | NASDAQ:BTSG | $10.63 Billion | $66.89 |
Market Capitalization of Opyl Ltd (2015–2025)
Market capitalization of Opyl Ltd from 2015 to today. Between 2015 and today, Opyl Ltd's market cap moved from $1.89 Billion to $ 4.82 Million, with a yearly change of -45.14%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2025 | AU$4.82 Million | +21.05% |
| 2024 | AU$3.98 Million | -32.14% |
| 2023 | AU$5.87 Million | -3.45% |
| 2022 | AU$6.08 Million | -74.78% |
| 2021 | AU$24.09 Million | -34.29% |
| 2020 | AU$36.66 Million | +25.00% |
| 2019 | AU$29.33 Million | -30.00% |
| 2018 | AU$41.90 Million | -60.00% |
| 2017 | AU$104.75 Million | -54.55% |
| 2016 | AU$230.45 Million | -87.78% |
| 2015 | AU$1.89 Billion | -- |
End of Day Market Cap According to Different Sources
On Sep 24th, 2026 the market cap of Opyl Ltd was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $4.82 Million USD |
| MoneyControl | $4.82 Million USD |
| MarketWatch | $4.82 Million USD |
| marketcap.company | $4.82 Million USD |
| Reuters | $4.82 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Opyl Ltd
Pathkey.AI Ltd engages in the development of digital tools that enhance healthcare experience for patients in Australia. The company offers TrialKey, an AI-driven clinical trial optimization and success prediction platform, that simulate and optimize trial designs for pharmaceuticals, medical devices, alternative therapies, and novel conditions. It also provides TrialGen, an AI-powered tool strea… Read more